It looks like your are using Internet Explorer.
Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.
To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.
Proving DTx Efficacy and Safety
What is the most efficient way for DTx companies to generate evidence? DTx companies often struggle with proving efficacy and safety, especially small companies with limited resources. Often, DTx are asked to follow the same standards as traditional drugs. As DTx solutions are ever-evolving, this is difficult to achieve. Join the HealthXL DTx community in this meeting to discuss:
- How to successfully build an evidence generation strategy aligned with a commercial strategy?
- Best practices to measure efficacy and safety of DTx: Randomized Controlled Trial (RCT) design (sham DTx, comparators, participants diversity, etc) and the role of other types of clinical studies.
- The iterative nature of DTx products: how is the testing cycle different in digital products compared to drugs and how do we deal with that? How can the industry work towards new standards/guidelines for DTx that are used across the industry?
- Evidence requirements and how they depend on the stakeholders and characteristics of the DTx product (e.g. Prescription Digital Therapeutics (PDT) vs. non-PDT, standalone vs. drug-DTx combination)?
An invite invite link has been sent to you if you do not already have a HealthXL account.
An invite link will be sent to your inbox.
Proving DTx Efficacy and Safety
Proving DTx Efficacy and Safety
Join this HealthXL Event today:
Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.
You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.
Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.
What is the most efficient way for DTx companies to generate evidence? DTx companies often struggle with proving efficacy and safety, especially small companies with limited resources. Often, DTx are asked to follow the same standards as traditional drugs. As DTx solutions are ever-evolving, this is difficult to achieve. Join the HealthXL DTx community in this meeting to discuss:
- How to successfully build an evidence generation strategy aligned with a commercial strategy?
- Best practices to measure efficacy and safety of DTx: Randomized Controlled Trial (RCT) design (sham DTx, comparators, participants diversity, etc) and the role of other types of clinical studies.
- The iterative nature of DTx products: how is the testing cycle different in digital products compared to drugs and how do we deal with that? How can the industry work towards new standards/guidelines for DTx that are used across the industry?
- Evidence requirements and how they depend on the stakeholders and characteristics of the DTx product (e.g. Prescription Digital Therapeutics (PDT) vs. non-PDT, standalone vs. drug-DTx combination)?
Participants
Participants
Myles Furnace
Commercial VP, Closed Loop Medicine
Shaheen Lakhan
Chief Medical Officer , Click Therapeutics
Stephen Egan
Director, Redicare
Jordan Abdi, MD
Director Growth Operations, Holmusk
Randy Horton
Chief Solutions Officer, Orthogonal
Karine Soulat
Consultant, Wellthy Therapeutics
Maxime Champain
Lead, BDH External Innovation & Alliances, Search & Evaluation, Biogen
Brian Binkowski
Director of Quality, Twill
Chris Cera
CEO, Arcweb Technologies
Manpreet Kaur
Clinical Research Data Director, Anthem Inc
Anish Shindore
Founder & Managing Partner, GSD Health
Up to 12
Proving DTx Efficacy and Safety
What is the most efficient way for DTx companies to generate evidence? DTx companies often struggle with proving efficacy and safety, especially small companies with limited resources. Often, DTx are asked to follow the same standards as traditional drugs. As DTx solutions are ever-evolving, this is difficult to achieve. Join the HealthXL DTx community in this meeting to discuss:
- How to successfully build an evidence generation strategy aligned with a commercial strategy?
- Best practices to measure efficacy and safety of DTx: Randomized Controlled Trial (RCT) design (sham DTx, comparators, participants diversity, etc) and the role of other types of clinical studies.
- The iterative nature of DTx products: how is the testing cycle different in digital products compared to drugs and how do we deal with that? How can the industry work towards new standards/guidelines for DTx that are used across the industry?
- Evidence requirements and how they depend on the stakeholders and characteristics of the DTx product (e.g. Prescription Digital Therapeutics (PDT) vs. non-PDT, standalone vs. drug-DTx combination)?
HealthXL Meetings
HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.
Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.
Digital Health Meetings are fully interactive and promote conversation - be ready to talk!
HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.
No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.
Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.
Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.
Join from anywhere
No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.
The world of Digital Health in one Hub
Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers.
As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.
Our community is growing fast. Don’t miss out on your opportunity to lead the future.
News
Your Digital Health Corner
All Posts%20(1).png)
.png)
%20(2).png)
Beyond Patient Engagement: Why Collaboration is Essential in Health Tech
Read More
Frequently Asked Questions
What is a HealthXL Digital Health Meeting?
HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.
How can I become a member of the Digital Health Community?
We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.
When can I access the Meeting recording?
Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.
I am participating in this meeting, but can't attend anymore. Can I cancel it?
It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.
Proving DTx Efficacy and Safety
Proving DTx Efficacy and Safety
Proving DTx Efficacy and Safety
What is the most efficient way for DTx companies to generate evidence? DTx companies often struggle with proving efficacy and safety, especially small companies with limited resources. Often, DTx are asked to follow the same standards as traditional drugs. As DTx solutions are ever-evolving, this is difficult to achieve. Join the HealthXL DTx community in this meeting to discuss:
- How to successfully build an evidence generation strategy aligned with a commercial strategy?
- Best practices to measure efficacy and safety of DTx: Randomized Controlled Trial (RCT) design (sham DTx, comparators, participants diversity, etc) and the role of other types of clinical studies.
- The iterative nature of DTx products: how is the testing cycle different in digital products compared to drugs and how do we deal with that? How can the industry work towards new standards/guidelines for DTx that are used across the industry?
- Evidence requirements and how they depend on the stakeholders and characteristics of the DTx product (e.g. Prescription Digital Therapeutics (PDT) vs. non-PDT, standalone vs. drug-DTx combination)?
Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.
All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.
Frequently asked questions:
What are HealthXL Virtual Meetings?
HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.
How can I connect with other digital health leaders?
HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.
What are the benefits of being a HealthXL community member?
As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.
Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.
